Dangerous (toxic) atmospheres in UK wood pellet and wood chip fuel storage.

There is growing use of wood pellet and wood chip boilers in the UK. Elsewhere fatalities have been reported, caused by carbon monoxide poisoning following entry into wood pellet storage areas. The aim of this work was to obtain information on how safely these two fuels are being stored in the UK. Site visits were made to six small-scale boiler systems and one large-scale pellet warehouse, to assess storage practice, risk management systems and controls, user knowledge, and potential for exposure to dangerous atmospheres. Real time measurements were made of gases in the store rooms and during laboratory tests on pellets and chips. Volatile organic compounds (VOCs) emitted and the microbiological content of the fuel was also determined. Knowledge of the hazards associated with these fuels, including confined space entry, was found to be limited at the smaller sites, but greater at the large pellet warehouse. There has been limited risk communication between companies supplying and maintaining boilers, those manufacturing and supplying fuel, and users. Risk is controlled by restricting access to the store rooms with locked entries; some store rooms have warning signs and carbon monoxide alarms. Nevertheless, some store rooms are accessed for inspection and maintenance. Laboratory tests showed that potentially dangerous atmospheres of carbon monoxide and carbon dioxide, with depleted levels of oxygen may be generated by these fuels, but this was not observed at the sites visited. Unplanned ventilation within store rooms was thought to be reducing the build-up of dangerous atmospheres. Microbiological contamination was confined to wood chips.

Performance testing protocol for closed-system transfer devices used during pharmacy compounding and administration of hazardous drugs.

OBJECTIVES: The United States National Institute for Occupational Safety and Health (NIOSH) is developing a protocol to assess the containment performance of closed system transfer devices (CSTDs) when used for drug preparation (task 1) and administration (task 2) and published a draft protocol in September 2016. Nine possible surrogates were proposed by NIOSH for use in the testing. The objectives of this study were to: (A) select the most appropriate surrogate; (B) validate the NIOSH protocol using this surrogate; and (C) determine the containment performance of four commercial CSTDs as compared with an open system of needle and syringe using the validated NIOSH protocol. METHODS: 2-Phenoxyethanol (2-POE) was selected as a surrogate based on its water solubility, Henry's volatility constant, detectability by mass spectrometry, and non-toxicity. Standard analytical validation methods including system suitability, limit of detection (LOD), and limit of quantitation (LOQ) as well as system cleaning validation were performed. The amount of 2-POE released when the CSTDs were manipulated according to two tasks defined by NIOSH was determined using mass spectrometry coupled to thermal desorption and gas chromatography. This approach allows sensitivity of detection below 1 part per billion (ppb). Equashield, Tevadaptor (OnGuard), PhaSeal, and ChemoClave were assessed according to manufacturers' instructions for use. RESULTS: 2-POE was tested and validated for suitability of use within the NIOSH protocol. A simple and efficient cleaning protocol achieved consistently low background values, with an average value, based on 85 measurements, of 0.12 ppb with a 95% confidence interval (CI) of ±0.16 ppb. This gives an LOD for the tests of 0.35 ppb and an LOQ of 0.88 ppb. The Equashield, Tevadaptor (OnGuard), and PhaSeal devices all showed average releases, based on 10 measurements from five tests, that were less than the LOQ (i.e. < 0.88 ppb), while the ChemoClave Vial Shield with Spinning Spiros showed average releases of 2.9±2.3 ppb and 7.5±17.9 ppb for NIOSH tasks 1 and 2 respectively at the 95% confidence level. The open system of needle and syringe showed releases, based on two measurements from a single test, of 4.2±2.2 ppb and 5.1±1.7 ppb for NIOSH tasks 1 and 2 respectively at the 95% confidence level. CONCLUSIONS: 2-POE proved to be an ideal surrogate for testing of CSTDs using the NIOSH protocol. We propose that a CSTD can be qualified using the NIOSH testing approach if the experimental LOQ is less than 1 ppb and the release values are below the LOQ. Equashield, Tevadaptor (OnGuard), and PhaSeal meet these acceptance criteria and can therefore all be qualified as CSTDs, but the ChemoClave system does not and so would not qualify as a CSTD.

Evaluation of diffusive samplers and photoionisation detectors for measuring very short peak exposures in the workplace.

The extent to which very short peak widths, peak frequency, sampling time and post-sampling/pre-capping time impact upon occupational exposure measurements of toluene has been investigated using diffusive tubes. Additionally, the effect of the width of the peak on the estimation of peak maximum concentration and time-weighted average (TWA) concentration from real-time instruments (photoionisation detectors-PIDs) was also studied, and their responses modelled. No clear differences were perceived between diffusive and pumped tube results. Mean biases of -5 to +6% were recorded but no trend could be distinguished with respect to any of the variables examined; the main source of uncertainty was attributed to analytical uncertainty. The diffusive tubes can therefore be used to measure short term transient toluene concentrations (e.g. 5 s duration) over short (15 min) exposure periods. The two slower responding PIDs (t50 = 4 s) underestimated the maximum concentration of short term peaks having durations less than 10 s. The other three PIDs (t50 < or = 2 s) only significantly underestimated the maximum concentration of short term peaks having durations of 2 s and below. Pulse duration appeared to affect the PID's estimation of peak height more than peak area (TWA concentration).